Evidence map›Paper›PMID 34737608›Full record

ArticleInternational journal of general medicine2021

Significance of TEAD Family in Diagnosis, Prognosis and Immune Response for Ovarian Serous Carcinoma.

Xinxin Ren, Xiang Wang, Bi Peng, Qiuju Liang, Yuan Cai, Kewa Gao, Yongbin Hu, Zhijie Xu, Yuanliang Yan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of general medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. TEAD4 as an Oncogene and a Mitochondrial Modulator.Frontiers in cell and developmental biology · 2022
    Review
  4. Current progress of ferroptosis study in ovarian cancer.Frontiers in molecular biosciences · 2022
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Xinxin RenCenter for Molecular Medicine, Xiangya Hospital, Central South University, Changsha, People's Republic of China.ORCID 0000-0003-0851-0462
Xiang WangDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Bi PengDepartment of Pathology, Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Qiuju LiangDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Yuan CaiDepartment of Pathology, Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Kewa GaoDepartment of Pathology, Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Yongbin HuDepartment of Pathology, Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Zhijie XuDepartment of Pathology, Xiangya Hospital, Central South University, Changsha, People's Republic of China.ORCID 0000-0003-2047-883X
Yuanliang YanDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha, People's Republic of China.
Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo explore the molecular profiles of transcriptional enhanced associate domain (

methodsIn this study, we use bioinformatics methods including GEPIA, GE-mini, Oncomine 3.0, Kaplan-Meier plotter, cBioPortal, WebGestalt, TIMER2.0 and DiseaseMeth2.0, and in vitro experimental RT-PCR to assess the expression profiles and prognostic significance of

resultsAccording to the bioinformatics analysis,

conclusionThus,

Indexed as

expression profilesHippo pathwayimmune infiltrationovarian serous carcinomaprognosisTEAD family

Identifiers

PMID34737608
PMCPMC8558638
OpenAlexW3210418751

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.